IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v17y2020i5p1494-d325210.html
   My bibliography  Save this article

Hyperlipidemia and Statins Use for the Risk of New Diagnosed Sarcopenia in Patients with Chronic Kidney: A Population-Based Study

Author

Listed:
  • Min-Hua Lin

    (Department of Nutrition, China Medical University, Taichung 40402, Taiwan
    Department of Dietetics, Yunlin Christian Hospital, Yunlin 64866, Taiwan)

  • She-Yu Chiu

    (Department of Nutrition, China Medical University, Taichung 40402, Taiwan)

  • Pei-Hsuan Chang

    (Department of Clinical Nutrition, China Medical University Hospital, Taichung 40402, Taiwan
    Department of Public Health, China Medical University, Taichung 40402, Taiwan)

  • Yu-Liang Lai

    (Department of Physical Therapy Medicine and rehabilitation, China Medical University, Hsinchu 302, Taiwan
    Department of Physical Therapy and School of Medicine, China Medical University, Taichung 40402, Taiwan)

  • Pau-Chung Chen

    (Department of Public Health, National Taiwan University, Taipei 10617, Taiwan)

  • Wen-Chao Ho

    (Department of Public Health, China Medical University, Taichung 40402, Taiwan)

Abstract

Background : Previous research found that statins, in addition to its efficiency in treating hyperlipidemia, may also incur adverse drug reactions, which mainly include myopathies and abnormalities in liver function. Aim: This study aims to assess the risk for newly onset sarcopenia among patients with chronic kidney disease using statins. Material and Method: In a nationwide retrospective population-based cohort study, 75,637 clinically confirmed cases of chronic kidney disease between 1997 and 2011were selected from the National Health Insurance Research Database of Taiwan. The selection of the chronic kidney disease cohort included a discharge diagnosis with chronic kidney disease or more than 3 outpatient visits with the diagnosis of chronic kidney disease found within 1 year. After consideration of patient exclusions, we finally got a total number of 67,001 cases of chronic kidney disease in the study. The Cox proportional hazards model was used to perform preliminary analysis on the effect of statins usage on the occurrence of newly diagnosed sarcopenia; the Cox proportional hazards model with time-dependent covariates was conducted to take into consideration the individual temporal differences in medication usage, and calculated the hazard ratio (HR) and 95% confidence interval after controlling for gender, age, income, and urbanization. Results: Our main findings indicated that patients with chronic kidney disease who use statins seem to effectively prevent patients from occurrences of sarcopenia, high dosage of statins seem to show more significant protective effects, and the results are similar over long-term follow-up. In addition, the risk for newly diagnosed sarcopenia among patients with lipophilic statins treatment was lower than that among patients with hydrophilic statins treatment. Conclusion: It seems that patients with chronic kidney disease could receive statin treatment to reduce the occurrence of newly diagnosed sarcopenia. Additionally, a higher dosage of statins could reduce the incidence of newly diagnosed sarcopenia in patients with chronic kidney disease.

Suggested Citation

  • Min-Hua Lin & She-Yu Chiu & Pei-Hsuan Chang & Yu-Liang Lai & Pau-Chung Chen & Wen-Chao Ho, 2020. "Hyperlipidemia and Statins Use for the Risk of New Diagnosed Sarcopenia in Patients with Chronic Kidney: A Population-Based Study," IJERPH, MDPI, vol. 17(5), pages 1-16, February.
    • Handle: RePEc:gam:jijerp:v:17:y:2020:i:5:p:1494-:d:325210
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/17/5/1494/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/17/5/1494/
    Download Restriction: no
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Chien-Lung Chan & Chi-Chang Chang, 2020. "Big Data, Decision Models, and Public Health," IJERPH, MDPI, vol. 17(18), pages 1-7, September.
    2. Chien-Lung Chan & Chi-Chang Chang, 2022. "Big Data, Decision Models, and Public Health," IJERPH, MDPI, vol. 19(14), pages 1-9, July.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:17:y:2020:i:5:p:1494-:d:325210. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.